We are committed to therapeutic progress to serve patient needs. Servier is present in Vietnam since 1993. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. We are a leader in cardiology, our ambition is to become a recognized and innovative player in oncology. The corporate growth is driven by our constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric disease, cancer and diabetes, as well as by our activities in high-quality generic drugs. All Group employees are driven by shared Values and guided by a common Vision. Together we share the passion of entrepreneurship and we are committed to therapeutic progress to serve patient needs. ------ To report a suspected adverse event with a Servier drug, please visit https://www.servier.vn/content/lien-he